Valvular interstitial cells suppress calcification of valvular endothelial cells

Atherosclerosis. 2015 Sep;242(1):251-260. doi: 10.1016/j.atherosclerosis.2015.07.008. Epub 2015 Jul 17.

Abstract

Background: Calcific aortic valve disease (CAVD) is the most common heart valve disease in the Western world. We previously proposed that valvular endothelial cells (VECs) replenish injured adult valve leaflets via endothelial-to-mesenchymal transformation (EndMT); however, whether EndMT contributes to valvular calcification is unknown. We hypothesized that aortic VECs undergo osteogenic differentiation via an EndMT process that can be inhibited by valvular interstitial cells (VICs).

Approach and results: VEC clones underwent TGF-β1-mediated EndMT, shown by significantly increased mRNA expression of the EndMT markers α-SMA (5.3 ± 1.2), MMP-2 (13.5 ± 0.6) and Slug (12 ± 2.1) (p < 0.05), (compared to unstimulated controls). To study the effects of VIC on VEC EndMT, clonal populations of VICs were derived from the same valve leaflets, placed in co-culture with VECs, and grown in control/TGF-β1 supplemented media. In the presence of VICs, EndMT was inhibited, shown by decreased mRNA expression of α-SMA (0.1 ± 0.5), MMP-2 (0.1 ± 0.1), and Slug (0.2 ± 0.2) (p < 0.05). When cultured in osteogenic media, VECs demonstrated osteogenic changes confirmed by increase in mRNA expression of osteocalcin (8.6 ± 1.3), osteopontin (3.7 ± 0.3), and Runx2 (5.5 ± 1.5). The VIC presence inhibited VEC osteogenesis, demonstrated by decreased expression of osteocalcin (0.4 ± 0.1) and osteopontin (0.2 ± 0.1) (p < 0.05). Time course analysis suggested that EndMT precedes osteogenesis, shown by an initial increase of α-SMA and MMP-2 (day 7), followed by an increase of osteopontin and osteocalcin (day 14).

Conclusions: The data indicate that EndMT may precede VEC osteogenesis. This study shows that VICs inhibit VEC EndMT and osteogenesis, indicating the importance of VEC-VIC interactions in valve homeostasis.

Keywords: Calcific aortic valve disease; Calcification; Endothelial-to-mesenchymal transformation; Valvular endothelial cells; Valvular interstitial cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aortic Valve / drug effects
  • Aortic Valve / metabolism
  • Aortic Valve / pathology*
  • Aortic Valve Stenosis / genetics
  • Aortic Valve Stenosis / metabolism
  • Aortic Valve Stenosis / pathology*
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Biomarkers / metabolism
  • Calcinosis / genetics
  • Calcinosis / metabolism
  • Calcinosis / pathology*
  • Cell Communication* / drug effects
  • Cell Differentiation* / drug effects
  • Cell Differentiation* / genetics
  • Cell Movement
  • Cells, Cultured
  • Coculture Techniques
  • Culture Media / metabolism
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology*
  • Epithelial-Mesenchymal Transition
  • Gene Expression Regulation
  • Humans
  • Male
  • Mice, Knockout
  • Osteogenesis* / drug effects
  • Osteogenesis* / genetics
  • RNA, Messenger / metabolism
  • Sheep
  • Time Factors
  • Transforming Growth Factor beta1 / pharmacology

Substances

  • Apolipoproteins E
  • Biomarkers
  • Culture Media
  • RNA, Messenger
  • Transforming Growth Factor beta1

Supplementary concepts

  • Aortic Valve, Calcification of